Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ochoa

Showing results (341-350 of 368) with videos related to

Pageof 37
Sort By:
Molecular Therapy. Nucleic Acids|August 31, 2023
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonistsAssunta Cirella, Elixabet Bolaños, Carlos Luri-Rey, et al.
Science Advances|August 18, 2023
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effectsJavier Glez-Vaz, Arantza Azpilikueta, María C Ochoa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancerB D Curti, A C Ochoa, G C Powers, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1996
Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patientsB D Curti, A C Ochoa, W J Urba, et al.
International Journal of Cancer|October 2, 2020
Comparison of immediate colposcopy, repeat conventional cytology and hrHPV testing for the clinical management of ASC-US cytology in routine health services of Medellin, Colombia: The ASCUS-COL TrialArmando Baena, Maria C Agudelo, Carolina Lopez, et al.
Cancer Immunology Research|January 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T cells Antitumor Immunity Through Metabolic ReprogrammingPhaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino, et al.
Cancer Discovery|June 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1βIrene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños, et al.
Ebiomedicine|March 6, 2022
Increased inflammatory low-density neutrophils in severe obesity and effect of bariatric surgery: Results from case-control and prospective cohort studiesMaria Dulfary Sanchez-Pino, William S Richardson, Jovanny Zabaleta, et al.
Plos One|March 4, 2021
Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasmaFor Yue Tso, Salum J Lidenge, Lisa K Poppe, et al.
Cancers|August 10, 2024
Insulin Resistance in Women Correlates with Chromatin Histone Lysine Acetylation, Inflammatory Signaling, and Accelerated AgingChristina M Vidal, Jackelyn A Alva-Ornelas, Nancy Zhuo Chen, et al.
Pageof 37

Showing results (341-350 of 368) with videos related to

Sort By:
Pageof 37
Molecular Therapy. Nucleic Acids|August 31, 2023
Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonistsAssunta Cirella, Elixabet Bolaños, Carlos Luri-Rey, et al.
Science Advances|August 18, 2023
CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effectsJavier Glez-Vaz, Arantza Azpilikueta, María C Ochoa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancerB D Curti, A C Ochoa, G C Powers, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1996
Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patientsB D Curti, A C Ochoa, W J Urba, et al.
International Journal of Cancer|October 2, 2020
Comparison of immediate colposcopy, repeat conventional cytology and hrHPV testing for the clinical management of ASC-US cytology in routine health services of Medellin, Colombia: The ASCUS-COL TrialArmando Baena, Maria C Agudelo, Carolina Lopez, et al.
Cancer Immunology Research|January 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T cells Antitumor Immunity Through Metabolic ReprogrammingPhaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino, et al.
Cancer Discovery|June 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1βIrene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños, et al.
Ebiomedicine|March 6, 2022
Increased inflammatory low-density neutrophils in severe obesity and effect of bariatric surgery: Results from case-control and prospective cohort studiesMaria Dulfary Sanchez-Pino, William S Richardson, Jovanny Zabaleta, et al.
Plos One|March 4, 2021
Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasmaFor Yue Tso, Salum J Lidenge, Lisa K Poppe, et al.
Cancers|August 10, 2024
Insulin Resistance in Women Correlates with Chromatin Histone Lysine Acetylation, Inflammatory Signaling, and Accelerated AgingChristina M Vidal, Jackelyn A Alva-Ornelas, Nancy Zhuo Chen, et al.
Pageof 37